Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Sage Therapeutics, Inc. | d862496dex231.htm |
| EX-31.1 - EX-31.1 - Sage Therapeutics, Inc. | d862496dex311.htm |
| EX-21.1 - EX-21.1 - Sage Therapeutics, Inc. | d862496dex211.htm |
| EX-31.2 - EX-31.2 - Sage Therapeutics, Inc. | d862496dex312.htm |
| EX-10.23 - EX-10.23 - Sage Therapeutics, Inc. | d862496dex1023.htm |
| EX-10.20 - EX-10.20 - Sage Therapeutics, Inc. | d862496dex1020.htm |
| EX-10.22 - EX-10.22 - Sage Therapeutics, Inc. | d862496dex1022.htm |
| EX-10.21 - EX-10.21 - Sage Therapeutics, Inc. | d862496dex1021.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Sage Therapeutics, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Sage Therapeutics, Inc. | d862496d10k.htm |
| EX-10.24 - EX-10.24 - Sage Therapeutics, Inc. | d862496dex1024.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Sage Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2014 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 6, 2015 | /s/ Jeffrey M. Jonas | |||||
| Jeffrey M. Jonas, M.D. | ||||||
| Chief Executive Officer, President and Director | ||||||
| (Principal Executive Officer) | ||||||
| Dated: March 6, 2015 | /s/ Kimi Iguchi | |||||
| Kimi Iguchi | ||||||
| Chief Financial Officer and Secretary | ||||||
| (Principal Financial Officer) | ||||||